Article
Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
2025-11-26
Abstract excerpt
<h4>Background: </h4> Alopecia areata (AA) is an autoimmune disorder characterized by non-scarring hair loss. Janus kinase inhibitors (JAKi), such as baricitinib, show therapeutic benefit; however, the underlying mechanisms and reliable predictors of response remain insufficiently defined. <h4>Methods: </h4>: In this real-world study, 74 Chinese patients with severe AA received baricitinib for up to 36 weeks. Cli...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a6210266-ef34-51cc-8737-747c25574f10
- DOI
- 10.22541/au.176415513.33647330/v1
